Skip to main content
Fig.11 | Cancer Cell International

Fig.11

From: Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75

Fig.11

PIK-75 inhibit the growth of BCa in vitro and in vivo. A, B CCK8 assay (A) and colony formation assay (B) of BCa cells. C A wound-healing assay of BCa cells. D The FACS results of Annexin V-PE/7-AAD staining after PIK-75- or DMSO-treated. E, F Morphological changes (E) and 3D cell viability assay (F) of BCa organoids after PIK-75- or DMSO-treated. G Images of the xenograft tumors from MB49 cells subcutaneously injected c57BL/6 mice and tumor growth curves were plotted. The mice were subjected to intraperitoneal administration (i.p.) of PIK-75 or DMSO (as a control) following tumor establishment

Back to article page